🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.

Recruitingn/aAges 18 Years - anyAllUniversity of Bordeaux
NCT07734363 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Substance/Alcohol Use disorders are defined as a loss of control over the use despite harmul consequences, as well as an intense and persistent urge to use, also called craving. Previous research has shown that craving is central among the diagnostic criteria for addiction, suggesting that it may be important in the onset and persistence of addiction. Addiction develops progressively, and it appears crucial to identify predictive markers of the transition from one level of severity to another over time. One hypothesis is that more closely linked symptoms (meaning symptoms that influence each other more) could be associated with greater severity and/or with the evolution of addiction severity over time. The aim of this project is to explore how the characteristics of the association between addiction symptoms (diagnostic criteria and symptoms as they occur in daily life), and the import

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria * Be over 18 years of age * Identify a primary substance as a main problematic substance use. * Be a regular user (at least twice a week in the last 30 days) of a primary substance (defined as their main problematic substance use). * Present a current diagnosis of SUD for this primary substance according to DSM-5 criteria. Exclusion Criteria * Medical, psychiatric or addiction condition that warrants immediate inpatient treatment intervention. * Somatic, cognitive or other disorders preventing the use of the smartphone device (deafness, impaired vision, illiteracy….). * Not being familiar with the use of smartphone * Having a smartphone not compatible with the application and being unable to visit the laboratory to receive a loaner phone for the study. * Difficulty in understanding and/or writing and/or reading French. * Individuals participating in another study that includes an ongoing exclusion period. * Be deprived of liberty due to an ongoing legal procedure. * Be under legal protection. * Be under guardianship or conservatorship.
💊

What it tests

  • Observational assessments (EMA and annual DSM-5 evaluations)
📍

Where

1 site
Université de Bordeaux CNRS UMR 6033 SANPSY
Bordeaux, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy